Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Frontiers in Microbiology|August 23, 2023
Effects of dietary L-Citrulline supplementation on growth performance, meat quality, and fecal microbial composition in finishing pigsJunhua Du, Mailin Gan, Zhongwei Xie, et al.
Oncoimmunology|September 23, 2022
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapyJiwei Huang, Ruopeng Su, Zeyu Chen, et al.
Urologic Oncology|August 10, 2023
Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomyJiwei Huang, Ruopeng Su, Cuijian Zhang, et al.
Biomaterials|August 26, 2025
A proactive cholinergic-like acidic fibroblast growth factor delivery system for efficient protein enrichment and native drug release in the central nervous system to promote repair of injured spinal cordDawei Jiang, Zhiyang Huang, Peng Dai, et al.
Cancer Medicine|March 23, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world studyRuopeng Su, Zeyu Chen, Daoping Hong, et al.
Cancer Medicine|September 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective studyRuopeng Su, Tingxuan Huang, Liangyou Gu, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world studyCheoklong Ng, Taile Jing, Shicheng Yu, et al.
Clinical Genitourinary Cancer|May 10, 2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell CarcinomaCheoklong Ng, Cheng Peng, Shangqian Wang, et al.
Pageof 7